CSDAP original content, policy statements, research and general communications.

Multiple Pathways to Recovery: A Cause for Hope


That there are multiple pathways to recovery has been an axiom of the recovery community for years. This principle — that we do best when we support and encourage many approaches to recovery — goes hand-in-hand with the recognition that recovery is never a one-shot deal. Instead, it is a process that unfolds over time. …Read more

New FDA draft MAT guidelines raise disturbing questions


The Food and Drug Administration (FDA) has just issued guidelines to the pharmaceutical industry in an attempt to encourage them to bring novel drugs to market to assist opioid addicts in their quest for recovery. Whether or not this is good news for any family seeking to save a loved one’s life depends on what …Read more

Medication-Assisted Treatment, another link in Big Pharma’s chain of addiction


We have been immersed recently in the opioid crisis, with headines of drug-fueled overdose deaths. Behind the headlines are the continuing stories of degradation, crime, disease, prostitution and murder. Addicts, some of whom became hooked first on prescribed pharmaceuticals have swollen the ranks of the homeless, the incarcerated and the dead. If you have an …Read more

Today’s Traveling Patent-Medicine Show

A hundred years ago, traveling shows peddled patent medicine, sometimes one step ahead of the authorities. Ingredients included opium, alcohol, laudanum, radium, and other illicit substances. Tapeworm larvae were sometimes suspended in weight-reduction remedies. By the time the authorities closed in, the wagon, the salesman and his wares were gone, leaving the purchaser or the …Read more

Drug Abuse Summit: Four Days, Three Takeaways


I attended my first Rx Drug Abuse and Heroin Summit recently, the first week of April 2018. It was a fascinating four days and gave me an entirely new level of understanding of the problem we’re facing with opioids and other drugs. That absolutely includes a better appreciation for the heroic, often thankless, job being …Read more

Review: Dreamland The True Tale of America’s Opiate Epidemic by Sam Quinones

In 2015, the book Dreamland hit the United States more or less like a bombshell. The research, interviews and writing of journalist Sam Quinones ripped the lid off our entire situation of addiction to painkillers and heroin. The full structure of our opioid epidemic was laid bare for anyone to see. How did we get …Read more

Study Reliability

Published, even peer-reviewed behavioral studies are subject to problems that must be accounted for when analyzing study results. Many of the “tricks-of-the-trade” are covered in Deciphering Drug Study Tricks-of-the-Trade but, somewhat ironically, general studies have been done on the reliability of behavioral studies. A study of psychological studies published in Science in 2015 entitled Estimating the reproducibility of …Read more

The Emperor’s New Drugs: Exploding the Antidepressant Myth

Summary: When he began a new research project on antidepressants and placebos (a “meta-analysis” of a large number of published studies), practicing psychotherapist and research psychologist Kirsch was surprised to uncover evidence that inadequate supervision by the FDA had allowed pharmaceutical companies to cherry-pick test results for publication and submission to the feds, suppressing unwanted …Read more

Dreamland, The True Tale of America’s Opiate Epidemic

Summary: With numerous awards and recommendations, this book is a “must read” if one wishes to really understand the origins of our current opioid and heroin crisis. With a great reporter’s narrative skill and the storytelling ability of a novelist, journalist Sam Quinones weaves together two classic tales of capitalism run amok whose unintentional collision …Read more